36 devices · GMDN 56754
Prostatic acid phosphatase (PAP) IVD antibody tests are in vitro diagnostic devices designed to detect the presence or measure levels of PAP in patient samples, such as blood or serum. Clinically, these tests support the evaluation of prostate-related conditions, including prostate cancer screening and monitoring treatment response, by identifying biomarkers linked to prostate health.
These devices are typically regulated as in vitro diagnostics, with classification and supply requirements varying by jurisdiction. They are used in laboratory settings and may require specific handling, storage, or validation protocols to ensure accurate and reliable results for clinical decision-making.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.